Page last updated: 2024-08-26

4-methylumbelliferyl-galactopyranoside and globotriaosylceramide

4-methylumbelliferyl-galactopyranoside has been researched along with globotriaosylceramide in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chiba, Y; Fukushige, T; Itoh, K; Jigami, Y; Kanekura, T; Kawashima, I; Kuroda, M; Ohashi, T; Ohno, K; Sakuraba, H; Sugawara, K; Suzuki, T; Tajima, Y; Togawa, T; Tsukimura, T1

Other Studies

1 other study(ies) available for 4-methylumbelliferyl-galactopyranoside and globotriaosylceramide

ArticleYear
Use of a modified alpha-N-acetylgalactosaminidase in the development of enzyme replacement therapy for Fabry disease.
    American journal of human genetics, 2009, Volume: 85, Issue:5

    Topics: alpha-N-Acetylgalactosaminidase; Amino Acid Substitution; Animals; Binding Sites; Catalysis; Cells, Cultured; CHO Cells; Cricetinae; Cricetulus; Culture Media, Conditioned; Disease Models, Animal; DNA, Complementary; Drug Stability; Enzyme Replacement Therapy; Fabry Disease; Fibroblasts; Fluorescent Dyes; Galactosides; Genetic Vectors; Humans; Hydrogen-Ion Concentration; Hymecromone; Immunohistochemistry; Kidney; Liver; Mice; Mice, Knockout; Models, Molecular; Molecular Weight; Myocardium; Recombinant Proteins; Retroviridae; Transfection; Trihexosylceramides

2009
chemdatabank.com